portal hypertension
Conditions
Interventions
Group 2:Multilayer bare stent
Group 3:Covered stent
Group 1:Bare stent
Sponsors
China-Japan Friendship Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Be able to understand the purpose of the trial, voluntarily participate in and sign the informed consent form, and be willing to accept the designated follow-up in this trial at a specific time point; 2. Aged 18-75 years (including 18 years old and 75 years old); 3. Patients who are clinically diagnosed with liver cirrhosis and have symptoms of portal hypertension, who are suitable for TIPS treatment; 4. Esophageal and gastric variceal bleeding confirmed by gastroscopy; 5. Moderate to severe ascites; 6. Child-Pugh score of liver function: 7-12 points.
Exclusion criteria
Exclusion criteria: 1. Total bilirubin>60 µmol/L (3.5 mg/dl); 2. Portal vein cavernous change; 3. Uncontrollable systemic infection or sepsis; 4. Those with serious diseases of heart, lung, kidney and other organs, and the expected survival is less than 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Technical successful rate;Bleeding and ascites control rate;TIPS shunt patency rate;Patients survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hepatic encephalopathy;Liver function; | — |
Countries
China
Contacts
Public ContactZhang Jianbin
China-Japan Friendship Hospital
Outcome results
None listed